Is Trazodone Safe for Sleep Long-Term?

Our Men's Wellness investigation already flagged that trazodone — one of five active ingredients in Strut Health's compounded Sleep Capsule — carries a real, FDA-mandated warning about increased suicidal thinking in patients under 25. That's the short-term disclosure. This question is the longer one: if a physician prescribes it for ongoing, night-after-night use, what does the actual research say about taking it that way?

First, the context most sleep-aid pages leave out

Trazodone was approved by the FDA in 1981 for one condition: major depressive disorder. It has never been FDA-approved for insomnia. Every prescription written for sleep — including as a component of a compounded formula like Sleep Capsule — is what's called off-label use: legal and common, but not something the FDA has specifically evaluated or approved for that purpose. That doesn't automatically make it unsafe, but it does mean the drug's official label wasn't written with nightly long-term sleep use as its evaluated case.

What the real long-term safety data actually shows

A 2023 clinical-inquiry review published by the American Academy of Family Physicians — summarizing the trial evidence and the American Academy of Sleep Medicine's own clinical guideline — concluded that trazodone should not be routinely used to treat insomnia. The reasoning wasn't that it does nothing: it modestly reduces the number of times someone wakes up during the night. But across the trials reviewed, it failed to meaningfully improve total sleep time, sleep efficiency, or how quickly someone falls asleep compared with placebo — and it produced more next-day side effects, including morning grogginess and dry mouth, than placebo did.

The more concrete long-term-use finding comes from a retrospective cohort study of over 313,000 U.S. adults treated for insomnia, published in Advances in Therapy. It found trazodone was associated with a fall rate of 5.27 per 100 person-years — higher than zolpidem extended-release (2.55), zolpidem immediate-release (2.99), and even higher than benzodiazepines (3.85), a drug class most people already think of as the riskier option. A separate Medicare-population study of nearly 1.7 million older adults found trazodone and benzodiazepines carried the greatest fall risk among the insomnia medications compared.

Neither study is about Strut Health's Sleep Capsule specifically — both look at trazodone prescribed on its own, often in older adults, at whatever dose a given physician chose. But they're the closest real evidence available to the actual question "what happens when people take trazodone for sleep over time," and the honest answer is: more falls, especially in older adults, and no strong evidence it meaningfully fixes the sleep problem it's most often prescribed for.

Why it's still commonly prescribed anyway

Trazodone remains one of the most-prescribed off-label sleep aids in the U.S. for reasons that are also real, not just marketing: unlike benzodiazepines and Z-drugs like zolpidem, it carries minimal abuse and physical-dependence potential. At the low doses typically used for sleep (25–100 mg, versus 150–600 mg for depression), side effects are generally milder than at antidepressant doses. And for some patients, the modest reduction in nighttime awakenings is a genuine, meaningful improvement, even if total sleep time doesn't change much on paper.

Stopping trazodone abruptly after extended use can also produce real withdrawal-type symptoms — irritability, mood changes, and rebound sleep disturbance — which is why tapering under a physician's guidance, rather than stopping cold, is the standard recommendation for long-term users.

Where this matters for Sleep Capsule specifically

Sleep Capsule isn't trazodone alone — it's a compounded formula combining trazodone with ramelteon, doxepin, hydroxyzine, and magnesium glycinate, each targeting a different sleep pathway. That's a genuinely different clinical picture than the single-ingredient trazodone studies above: a lower trazodone dose within a multi-ingredient formula isn't the same exposure as trazodone used as a standalone nightly sleep aid, and it hasn't been studied as its own combination in the fall-risk or efficacy research cited here. It also means more than one sedating ingredient in the same capsule, which is its own reason a prescribing physician should know your full medical history and current medications before approving it — the free MD consultation built into Strut Health's process exists specifically for that conversation.

The practical takeaway isn't "trazodone is dangerous" or "trazodone is fine" — it's that long-term, open-ended use of any trazodone-containing sleep formula is worth revisiting with your prescriber periodically, the same way you'd revisit any other long-term prescription, rather than treating a first approval as a permanent, unquestioned one.

Sources

• U.S. Food & Drug Administration — Trazodone Hydrochloride full prescribing information (boxed warning, approved indication)
• American Academy of Family Physicians / FPIN Clinical Inquiry — "Is Trazodone Effective and Safe for Treating Insomnia?" (2023)
• Advances in Therapy (PMC, National Institutes of Health) — "Fall Risk, Healthcare Resource Use, and Costs Among Adult Patients... Treated for Insomnia with Zolpidem, Trazodone, or Benzodiazepines" (retrospective cohort study, 313,000+ adults)

Not medical advice. Talk to a real prescribing physician or pharmacist before starting, continuing, or stopping trazodone or any sleep medication — especially if you're under 25, over 65, taking other sedating medications, or considering stopping after extended use. Questions about this piece? Email contact@healthyhealthsecrets.com. See also our About page and affiliate disclosure.